PM

Psychemedics CorpNASDAQ PMD Stock Report

Last reporting period 30 Jun, 2024

Updated 14 Nov, 2024

Last price

Market cap $B

0.014

Micro

Exchange

XNAS - Nasdaq

PMD Stock Analysis

PM

Uncovered

Psychemedics Corp is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-46/100

Low score

Market cap $B

0.014

Dividend yield

7.06 %

Shares outstanding

5.645 B

Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. The company is headquartered in Acton, Massachusetts and currently employs 139 full-time employees. The firm provides testing services for the detection of drugs of abuse through the analysis of hair samples. The Company’s testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The firm customize its enzyme immunoassay (EIA) procedures to drug test hair samples. The firm provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines, opiates, synthetic cannabinoids, benzodiazepines, nicotine and fentanyl. The firm markets its corporate drug testing services through its own sales force, distributors and webinars. The firm markets its home drug testing service, PDT-90, through the Internet.

View Section: Eyestock Rating